Agency IQ
SEPTEMBER 15, 2023
BY AMANDA CONTI SEP 13, 2023 1:58 PM CDT Quick background on nonprescription drug regulation Nonprescription drugs, also known as over-the-counter (OTC) drugs, are regulated differently than traditional prescription drugs. The FDA will follow these procedures for both agency-initiated operations (e.g.,
The Pharma Data
NOVEMBER 9, 2020
On August 20, 2018, the Company signed the Exclusive Dealing Agreement with Prof. He is also a current member of the Health Canada Scientific Advisory Committee on Pharmaceutical Sciences and Clinical Pharmacology and the Scientific Advisory Panel on Opioid Analgesic Abuse. SOURCE: XPhyto Therapeutics Corp. .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Agency IQ
OCTOBER 20, 2023
.” Interchangeable products can be substituted for the reference product at the pharmacy level, without prescriber intervention, within state and local regulations. For example, in 2018 the FDA published an extensive draft Q&A guidance document that answered 12 questions related to biosimilar or interchangeable products.
Agency IQ
JULY 12, 2024
The 53 regulations that FDA is currently working on The FDA on Friday unveiled its much-anticipated Spring 2024 Unified Agenda, a document outlining the regulations the agency plans to release in 2024 and beyond. Of those 53, seven are new to the Agenda, having never before been included in prior agendas.
The Pharma Data
FEBRUARY 8, 2021
Food and Drug Administration (FDA) approval for nmCRPC on February 14, 2018 and was approved for mCSPC on September 17, 2019. FDA on February 8, 2018. [vi] 2 ERLEADA ® received U.S. To date, more than 10,000 patients worldwide have been treated with ERLEADA ®. ERLEADA ® is taken orally, once daily, with or without food.
Expert insights. Personalized for you.
40 
Let's personalize your content